Skip to content
MMJ Gazette
  Wednesday 4 February 2026
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
January 31, 2026Colorado THC Vapes Flooded with Converted Hemp, Experts Sound Alarm January 29, 2026California Smashes Own Record: $609 Million in Illegal Cannabis Destroyed January 28, 2026Trump Allies Push to Kill Arizona Adult-Use Marijuana Sales January 18, 2026Florida’s Marijuana Legalization Battle Hits New Lows in 2026 January 16, 2026Montana Cannabis Sales Smash Records with $327 Million Haul January 15, 2026Cannabis M&A Surge Sparks Hope After Trump Order January 14, 2026Massachusetts Cannabis Ban Hit by Fraud Claims in 2026 Vote January 13, 2026Texas Medical Cannabis Set to Explode in 2026 January 10, 2026Cannabis Firms Face HR Compliance Crunch in 2026 January 9, 2026Oregon Cannabis Sales Drop in 2025 Despite Record Harvests
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Cannabis  Rubicon Organics Reports Strong Growth in 2023 Annual Report
CannabisNews

Rubicon Organics Reports Strong Growth in 2023 Annual Report

Lars BeckersLars Beckers—March 28, 20240
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Rubicon Organics Inc., a leading licensed producer of premium organic cannabis, has released its 2023 Annual Report, showcasing impressive financial results and strategic achievements. The company’s commitment to quality and innovation has solidified its position in the market, making it a force to be reckoned with.

Rubicon

 

Key Highlights from the 2023 Annual Report

1. Revenue Surge and Profitability

  • Net Revenue: Rubicon Organics achieved $40.1 million in net revenue for the twelve months ending December 31, 2023, marking a 13% increase compared to the previous year.
  • Adjusted EBITDA: The company reported $4.4 million in adjusted EBITDA during the same period, demonstrating consistent profitability.
  • Operating Cash Flow: Operating cash flow reached $5.0 million, reflecting the sixth consecutive quarter of positive cash flow.

2. Market Share and Brand Success

  • Premium Flower and Pre-Rolls: Rubicon Organics secured a 6.9% national market share in premium flower and pre-rolls, reinforcing its reputation for high-quality cannabis products.
  • Topical Dominance: The company’s brand, WildflowerTM, emerged as the number one topical brand in Canada, capturing an impressive 21.8% market share.
  • Premium Concentrates: Rubicon Organics claimed a 15.2% national market share in premium concentrates, further validating its market presence.

3. Award-Winning Recognition

  • Rubicon Organics received accolades, including the prestigious “Cannabis Company of the Year” and the “People’s Choice for Best Weed” awards.
  • The company’s commitment to excellence and product quality resonated with consumers and industry experts alike.

4. Product Expansion and Innovation

  • In 2023, Rubicon Organics diversified its product portfolio.
    • Edibles: The company entered the edibles market through a co-manufacturing relationship with 1964 Supply Co., launching Canada’s first single-strain live rosin edibles, which are vegan and gluten-free.
    • Wildflower™ Edibles: Wildflower introduced edibles containing minor cannabinoids (CBN, CBG, and CBD) alongside full-spectrum THC live rosin.
    • Topical Products: Wildflower expanded its offerings with products like the Extra Strength Relief Stick and the 1:1 CBD/THC Relief Stick.

5. Future Initiatives

  • Rubicon Organics plans to enter the vape market by leveraging additional biomass from its contract-grow strategy.
  • The highly anticipated launch of full spectrum extract (FSE) cured resin vapes under 1964 Supply Co. is expected to drive significant growth in 2024.

Conclusion

Rubicon Organics’ 2023 Annual Report underscores its commitment to quality, innovation, and sustainable growth. As the cannabis industry evolves, the company remains poised to lead the way with its premium organic offerings.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

A New Leaf in Cannabis Commerce: Kevin Nafte’s Strategic Move to Lyphe Australia
Arizona Cannabis Sales Reach $1.43 Billion in 2023
Related posts
  • Related posts
  • More from author
Marijuana

Colorado THC Vapes Flooded with Converted Hemp, Experts Sound Alarm

January 31, 20260
Cannabis

California Smashes Own Record: $609 Million in Illegal Cannabis Destroyed

January 29, 20260
Marijuana

Trump Allies Push to Kill Arizona Adult-Use Marijuana Sales

January 28, 20260
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Colorado THC Vapes Flooded with Converted Hemp, Experts Sound Alarm
  • California Smashes Own Record: $609 Million in Illegal Cannabis Destroyed
  • Trump Allies Push to Kill Arizona Adult-Use Marijuana Sales
  • Florida’s Marijuana Legalization Battle Hits New Lows in 2026
  • Montana Cannabis Sales Smash Records with $327 Million Haul
  • Cannabis M&A Surge Sparks Hope After Trump Order
  • Massachusetts Cannabis Ban Hit by Fraud Claims in 2026 Vote
  • Texas Medical Cannabis Set to Explode in 2026
  • Cannabis Firms Face HR Compliance Crunch in 2026
  • Oregon Cannabis Sales Drop in 2025 Despite Record Harvests
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors